Sign In
Buy TYME
$0.311
+0 (+0%)
At Close: Jan 27, 2023
BEDMINSTER, N.J.--(BUSINESS WIRE)--TYME Technologies, Inc. (“TYME” or the “Company”) (NASDAQ: TYME), an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs™),
TYME Technologies, Inc. to Present at Upcoming Virtual Healthcare Industry Conferences
06:50am, Thursday, 02'nd Sep 2021
BEDMINSTER, N.J.--(BUSINESS WIRE)--TYME Technologies, Inc. (Nasdaq: TYME) (the “Company” or “TYME”), an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs™),
Tyme Technologies: The Market Missed The Bullish Memo
06:45pm, Friday, 27'th Aug 2021
Tyme Technologies recently made some big moves following a strategic review. I believe the market has missed the bullish memo about these changes. I review some of these significant changes and provid
Tyme Technologies, Inc. (TYME) CEO Richie Cunningham on Q1 Fiscal Year 2022 Results - Earnings Call Transcript
10:31am, Tuesday, 10'th Aug 2021
Tyme Technologies, Inc. (TYME) CEO Richie Cunningham on Q1 Fiscal Year 2022 Results - Earnings Call Transcript
TYME Technologies, Inc. Provides Business Update and Announces Fiscal First Quarter 2022 Financial and Operating Results
06:45am, Tuesday, 10'th Aug 2021
BEDMINSTER, N.J.--(BUSINESS WIRE)--TYME Technologies, Inc. (Nasdaq: TYME) (the “Company” or “TYME”), an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs™),
TYME Technologies, Inc. to Host Conference Call and Webcast on Tuesday, August 10th at 8:30 AM ET
04:05pm, Monday, 02'nd Aug 2021
BEDMINSTER, N.J.--(BUSINESS WIRE)--TYME Technologies, Inc. (Nasdaq: TYME) (the “Company” or “TYME”), an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs™),
Tyme Technologies Stock Rallies: A Technical Analysis
01:06pm, Monday, 26'th Jul 2021
Shares of Tyme Technologies, Inc. (NASDAQ: TYME) may have just crashed into a wall of sellers. This means the rally may be over.
TYME Stock: The Cancer Treatment News That's Boosting Tyme Today
12:51pm, Monday, 26'th Jul 2021
TYME stock is making big moves today after it received patent approval for its cancer treatment. Now, it will move into deeper development.
Tyme Granted U.S. Patent Claims Covering Use of Tyrosine-Based Drug Delivery Method to Treat Cancer
08:05am, Monday, 26'th Jul 2021
BEDMINSTER, N.J.--(BUSINESS WIRE)--Tyme Technologies, Inc. (NASDAQ: TYME), an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs™), announced that it has received not
Best Biotech Penny Stocks to Buy? 3 to Watch Before Monday
09:05am, Friday, 11'th Jun 2021
Looking for biotech penny stocks to watch before Monday? Check these 3 out The post Best Biotech Penny Stocks to Buy?
Tyme Stock Is Trading Higher On Pipeline Update After Strategic Review, Q4 Earnings
07:26am, Friday, 11'th Jun 2021
Tyme Technologies Inc (NASDAQ: TYME) announced a breast cancer trial with Georgetown University named OASIS. Enrollment is expected to start in Q3 of 2021.
Tyme Technologies, Inc. (TYME) CEO Richie Cunningham on Q1 2021 Results - Earnings Call Transcript
10:23pm, Thursday, 10'th Jun 2021
Tyme Technologies, Inc. (TYME) CEO Richie Cunningham on Q1 2021 Results - Earnings Call Transcript
BEDMINSTER, N.J.--(BUSINESS WIRE)--Tyme Technologies, Inc. (Nasdaq:TYME) (the “Company” or “TYME”), an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs™), t
3 Biotech Penny Stocks That Are Popular on Reddit Right Now
04:45pm, Saturday, 29'th May 2021
Looking for biotech penny stocks on Reddit? Check these 3 out for your watchlist The post 3 Biotech Penny Stocks That Are Popular on Reddit Right Now appeared first on Penny Stocks to Buy, Picks, News
Tyme Technologies: Recent Sell-Off Provides Opportunity To Buy At A Discount
02:16am, Saturday, 29'th May 2021
Tyme Technologies continues to be a disappointing investment. Despite the discouraging price action, I am looking to accumulate shares in anticipation of the company's platform produces a game-changin
